Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome

Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome

In rats with polycystic ovary syndrome (PCOS) induced by injection of estradiol valerate (EV), unilateral or bilateral section of the vagus nerve restores ovulatory function in 75% of animals, suggesting that the vagus nerve participates in the development of PCOS. Since the vagus nerve is a mixed n...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Rosa Linares, Xóchitl N. Acuña, Gabriela Rosas, Elizabeth Vieyra, Deyra A. Ramírez, Andrea Chaparro, Julieta A. Espinoza, Roberto Domínguez, Leticia Morales-Ledesma
Format:	Artykuł
Język:	English
Wydane:	MDPI AG 2021-09-01
Seria:	Molecules
Hasła przedmiotowe:	PCOS acetylcholine atropine ovulation steroidogenesis
Dostęp online:	https://www.mdpi.com/1420-3049/26/18/5506

Podobne zapisy

In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation
od: Berenice Venegas, i wsp.
Wydane: (2019-11-01)

In Adult Rats With Polycystic Ovarian Syndrome, Unilateral or Bilateral Vagotomy Modifies the Noradrenergic Concentration in the Ovaries and the Celiac Superior Mesenteric Ganglia in Different Ways
od: Rosa Linares, i wsp.
Wydane: (2019-10-01)

Experience of Using Letrozole as a First-Line Ovulation Induction Agent in Polycystic Ovary Syndrome (PCOS)
od: Nupur Nandi *, Mahua Bhattacharya, Amit Tolasaria and Banasree Bhadra
Wydane: (2011-01-01)

Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome
od: Mohd Zahoor ul haq Shah, i wsp.
Wydane: (2023-04-01)

Pregnancies following the use of sequential treatment of metformin and incremental doses of letrozole in clomiphen-resistant women with polycystic ovary syndrome
od: Jafar Alavy Toussy, i wsp.
Wydane: (2012-01-01)

Efficacy of Metformin in Obese Versus non-Obese Women with Polycystic Ovary Syndrome (PCOS)
od: Fiza Ali Khan, i wsp.
Wydane: (2022-11-01)

The participation of the muscarinic receptors in the preoptic-anterior hypothalamic areas in the regulation of ovulation depends on the ovary
od: Adriana Espinosa-Valdez, i wsp.
Wydane: (2016-11-01)

The epoxiconazole and tebuconazole fungicides impair granulosa cells functions partly through the aryl hydrocarbon receptor (AHR) signalling with contrasted effects in obese, normo-weight and polycystic ovarian syndrome (PCOS) patients
od: Loise Serra, i wsp.
Wydane: (2024-06-01)

Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome
od: Maliheh Amirian, i wsp.
Wydane: (2021-08-01)

Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial
od: Srdjan Pandurevic, i wsp.
Wydane: (2023-06-01)

Effects of Metformin on Ovulation and Pregnancy Rate in Women with Clomiphene Resistant Poly Cystic Ovary Syndrome
od: Mahnaz Ashrafi, i wsp.
Wydane: (2007-03-01)

Ovulation induction techniques in women with polycystic ovary syndrome
od: Andreas A. Vyrides, i wsp.
Wydane: (2022-08-01)

Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial
od: Walid E. Mohammed, i wsp.
Wydane: (2022-02-01)

Induction ovulation with use of low dose HMG in patients with Clomiphene Citrate resistant polycystic ovary syndrome (PCOs)
od: T Nazari, i wsp.
Wydane: (2003-04-01)

Meta analysis of ovulation induction effect and pregnancy outcome of acupuncture & moxibustion combined with clomiphene in patients with polycystic ovary syndrome
od: Lijie Yang, i wsp.
Wydane: (2023-11-01)

The current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
od: Justyna Lipińska, i wsp.
Wydane: (2024-02-01)

Clomiphene Citrate versus Clomiphene Citrate in combination with other drugs in Ovulation Induction in Patients with Polycystic Ovary Syndrome
od: Mostafa Khodary, i wsp.
Wydane: (2025-07-01)

The role of metformin in ovulation induction: Current status
od: Aboubakr Mohamed Elnashar
Wydane: (2011-09-01)

The role of mast cells, C-fibers, and cholinergic transmission in the reduction of tracheal muscle and mronchi of sensitized animal
od: V.M. Kirilina, i wsp.
Wydane: (2020-12-01)

Predictors of metabolic syndrome among polycystic ovary syndrome sisters
od: Bindu Kulshreshtha, i wsp.
Wydane: (2019-01-01)

Organophosphate Poisoning and Cholinesterase Level: Case Report
od: Hashem Mohammed Mansour
Wydane: (2016-06-01)

Analysis of the responses of rats ileum to the effect of aqueous rhizome extract of zingiber officinale
od: F Agoreyo, i wsp.
Wydane: (2012-01-01)

Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review
od: Zhang Y, i wsp.
Wydane: (2025-02-01)

The pregnancy outcomes of infertile women with polycystic ovary syndrome undergoing intrauterine insemination with different attempts of previous ovulation induction
od: Yining Gao, i wsp.
Wydane: (2022-08-01)

Is combined letrozole and clomiphene superior to either as monotherapy: a systemic review and meta-analysis based on clinical trials
od: Anusha Ashkar, i wsp.
Wydane: (2024-12-01)

Vasoactive intestinal peptide modulates steroid hormone secretion via the superior ovarian nerve in a rat model of polycystic ovary syndrome
od: Gabriela Rosas Gavilán, i wsp.
Wydane: (2024-09-01)

Treatment of polycystic ovary syndrome in rats by kisspeptin
od: Zainab Alaulddin M. Hussien, i wsp.
Wydane: (2020-06-01)

A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome
od: Rachel S. Mandelbaum, M.D., i wsp.
Wydane: (2024-06-01)

Polycystic ovaries and infertility: Our experience
od: Lavanya Rajashekar, i wsp.
Wydane: (2008-01-01)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
od: Jeffrey N. Motter, i wsp.
Wydane: (2021-01-01)

Lean Polycystic Ovary Syndrome: A Narrative Review
od: Aboubakr Elnashar
Wydane: (2024-06-01)

Common endocrine disorders associated with the polycystic ovary syndrome
od: Ibrahim Abdelazim, i wsp.
Wydane: (2021-01-01)

Vitamin D supplementation in Polycystic ovary syndrome
od: Natalia Grzywna, i wsp.
Wydane: (2022-12-01)

Polycystic ovary syndrome (PCOS) - risk factor, diagnostic and current treatment
od: Justyna Wojcik, i wsp.
Wydane: (2020-09-01)

The latest reports and treatment methods on polycystic ovary syndrome
od: Natalia Anna Stańczak, i wsp.
Wydane: (2024-12-01)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
od: Pratap Kumar, i wsp.
Wydane: (2012-01-01)

POLYCYSTIC OVARY SYNDROME, LACTOGENESIS AND BREASTFEEDING
od: Irena Hren, i wsp.
Wydane: (2023-04-01)

Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
od: Raymond J Rodgers, i wsp.
Wydane: (2019-03-01)

Is elevated baseline SHBG associated with increased ovulation?
od: Hui Chang, i wsp.
Wydane: (2023-12-01)

Enhanced Ovarian Folliclular Development by Metformin Does Not Correlate with Pregnancy Rate: A Randomized Trial
od: Zahra Basirat, i wsp.
Wydane: (2012-04-01)